menu
    • menu

    Company profile for Revelation Biosciences

    NEW Drugs in Dev: 4
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Revelation Biosciences, Inc. is a clinical stage life sciences company focused on the development of immunologic‑based therapies for the prevention and treatment of disease. The Company has several product candidates in development. REVTx‑99, the lead therapeutic candidate, is an intranasal immunomodulator for the early treatment of SARS‑CoV‑2 infection. An expansion of REVTx‑99 therapeutic indications is planned tar...
    Revelation Biosciences, Inc. is a clinical stage life sciences company focused on the development of immunologic‑based therapies for the prevention and treatment of disease. The Company has several product candidates in development. REVTx‑99, the lead therapeutic candidate, is an intranasal immunomodulator for the early treatment of SARS‑CoV‑2 infection. An expansion of REVTx‑99 therapeutic indications is planned targeting early treatment and prevention of respiratory viral infection such as with influenza A or B, parainfluenza, and respiratory syncytial virus.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Revelation BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Menlo Park, CA 94205
    Telephone
    Telephone
    1-650-800-3717
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.revbiosciences.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/revelation-biosciences-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/RevBio1

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Revelation Biosciences Reveals Financial Results For Dec 2025
    Revelation Biosciences Reveals Financial Results For Dec 2025

    26 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-26/revelation-biosciences-inc-announces-financial-results-for-the-three-and-twelve-months-ended-decem

    PHARMIWEB
    26 Feb 2026
    Share Share
    Revelation Biosciences Announces 1-for-4 Reverse Stock Split
    Revelation Biosciences Announces 1-for-4 Reverse Stock Split

    26 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-26/revelation-biosciences-inc-announces-1-for-4-reverse-stock-split-effective-january-28-2026

    PHARMIWEB
    26 Jan 2026
    Share Share
    Revelation Biosciences Exercises Warrants, Raises $11M
    Revelation Biosciences Exercises Warrants, Raises $11M

    23 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-23/revelation-biosciences-inc-announces-exercise-of-warrants-for-11-million-in-gross-proceeds

    PHARMIWEB
    23 Jan 2026
    Share Share
    Revelation Biosciences Announces Nasdaq Inducement Grant
    Revelation Biosciences Announces Nasdaq Inducement Grant

    12 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-12/revelation-biosciences-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4

    PHARMIWEB
    12 Jan 2026
    Share Share
    Revelation Biosciences Starts GMP Manufacturing For GEMINI
    Revelation Biosciences Starts GMP Manufacturing For GEMINI

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/revelation-biosciences-announces-initiation-of-gmp-manufacturing-of-gemini-and-placebo-to-support-la

    PHARMIWEB
    07 Jan 2026
    Share Share
    Revelation Biosciences Reaches Quorum For Dec 3, 2025 Meeting
    Revelation Biosciences Reaches Quorum For Dec 3, 2025 Meeting

    01 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-01/revelation-biosciences-has-reached-a-quorum-for-its-december-3-2025-special-meeting

    PHARMIWEB
    01 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search